Notification of Qualification Group (QG2) Submission Window 2
Stage II Testing Results
Dear Mr. Silvestri:
In reference to Request for Information (RFI) HSTS04-12-SSN-CT5513, the Implant Sciences
Quantum Sniffer (QS) B220 Explosive Trace Detector (ETD) Stage II Testing results have been
evaluated by a Technical Review Panel (TRP), per section 5.8 of the RFI.
This letter is your Company’s official notification that The Transportation Security Administration (TSA) has deemed that the Implant Sciences QS B220 ETD device successfully met the minimum requirements per the “Systems Planning and Evaluation Performance Specification Aviation Cargo Explosive Trace Screening Device,” Version 2.01, August 15, 2012, “Management Plan for Cargo Explosives Trace Detection Equipment Qualification Testing and Evaluation,” Version 2.0 August 16, 2012, as well as the sufficiency evidence supplied during Stage I lab testing and Stage II field testing. As such, the TSA grants the Implant Sciences QS B220 ETD acceptance onto the “Qualified” section of the Air Cargo Security Technology List (ACSTL).
While the decision to move the system from “Approved” to “Qualified” was based on the sufficiency of evidence supplied during the Stage I and Stage II testing, TSA also took into consideration the current circumstances of the marketplace. Due to these circumstances, Implant Sciences was granted acceptance onto the “Qualified” section before the conclusion of Stage II testing. As described in section 4.1.2 of the RFI, the system will be required to remain active in
State II testing for the full 12 month time frame so that TSA can continue to evaluate the operational utility of the systems in an active cargo ship environment. Should the system prove deficient during the Stage II testing, TSA reserves the right to remove the system from the “Qualified” section.
In closing, I would like to personally thank you and your entire team for their hard work and effort in submitting a
It is most interesting that they did not wait until the end of Stage II testing to move it up to Qualified status. As stated normally it takes a full 12 months of Stage II testing. This is definitely a good sign.
That isn't the interesting part, the interesting part is that they did so because of "market place circumstances", i.e. the other guys #$%$ is being thrown off the list so they needed the Implant option quickly. Needing quickly means, sales will come quickly.
In closing, I would like to personally thank you and your entire team for their hard work and effort in submitting a response to this announcement.
Should you have any questions or wish to discuss further, please contact the Chairperson of the Technical Review Panel, Deborah Rooney at Deborah.Rooney@tsa.dhs.gov. Our best wishes in carrying out this important project.
/s/ Deborah L. Rooney
Chairperson, Technical Review Panel